UNSPSC 51373439: Codeine/guaifenesin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373439 Codeine/guaifenesin is a Commodity code for pharmaceutical preparations and controlled substances that state and local governments procure for correctional healthcare, emergency medical response, and community health initiatives. Recent solicitations show state and local buyers acquiring parenteral pharmaceutical products, naloxone, and drug-deactivation systems through competitive bidding — work that spans preparation, delivery, inventory management, and compliance with controlled-substance handling and medical-necessity protocols. The Washington State Department of Corrections and Seminole County, Florida represent the issuing-body mix: state correctional systems and county health departments. Work under this code involves meeting tight delivery windows (parenteral nutrition solutions within 24 hours, other IV products within 8 hours), maintaining cold-chain logistics and specialized storage, managing reorder cycles tied to patient census and acuity, and demonstrating documented clinical experience in IV solution preparation and monitoring. Contractors must hold state business licensure, pass background clearance, maintain professional liability and cyber-liability insurance, and comply with set-aside targets for minority, women-owned, disadvantaged, and veteran-owned businesses where the issuing body imposes them.

The code shows recent activity in the Pacific Northwest and Southeast. The Washington State Department of Corrections issued RFQ 13020 on September 8, 2026 for parenteral products, services, and equipment across eight correctional facilities in three regions (West, Central, East), with bids due October 7, 2026 and pre-bid conference September 23, 2026; DOC anticipates awarding up to three contractors per region with initial contract terms through June 30, 2030 and fixed pricing for the first two years. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 for 1,900 units of naloxone and 800 safe drug-deactivation systems annually with quarterly deliveries, though the listed response date of July 26, 2023 appears outdated in the source record. Both procurements emphasize rapid fulfillment, compliance with federal and state regulations, and participation from certified small and disadvantaged businesses.